4

OWNERSHIP DOCUMENT

Company: Protalix BioTherapeutics, Inc.
Filed: March 8, 2013
Period of Report: March 6, 2013
Accession Number: 0001144204-13-014057

View Document ↗ View on SEC.gov ↗